RevvityMEX:PKI 75 PB Ratio is 1.42 as of Jun. 27, 2026, which is 51% below its 10-year median of 2.90. GuruFocus rates MEX:PKI with a GF Score™ of 75/100 and a GF Value™ of MXN1,753.57. The stock has 11 warning signs investors should review. Among 196 Medical Diagnostics & Research companies, Revvity ranks better than 58.16% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-06-27), Revvity's share price is MXN1644.85. Revvity's Book Value per Share for the quarter that ended in Mar. 2026 was MXN1,160.31. Hence, Revvity's PB Ratio of today is 1.42.
Warning Sign:
Revvity Inc stock PB Ratio (=1.76) is close to 1-year high of 1.81.
The historical rank and industry rank for Revvity's PB Ratio or its related term are showing as below:
MEX:PKI'
s PB Ratio Range Over the Past 10 Years
Min: 1.28 Med: 2.9 Max: 5.06
Current: 1.76
During the past 13 years, Revvity's highest PB Ratio was 5.06. The lowest was 1.28. And the median was 2.90.
MEX:PKI's PB Ratio is ranked better than 58.16% of 196
companies
in the Medical Diagnostics & Research industry
Industry Median: 2.05
vs MEX:PKI: 1.76
During the past 12 months, Revvity's average Book Value Per Share Growth Rate was 0.60% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 3.40% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 11.30% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 16.30% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Revvity was 44.10% per year. The lowest was -5.40% per year. And the median was 6.70% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Revvity PB Ratio Related Terms
Revvity PB Ratio Historical Data
* Premium members only.
The historical data trend for Revvity's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Revvity's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Revvity PB Ratio vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Revvity's PB Ratio distribution charts can be found below:
* The bar in red indicates where Revvity's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Revvity's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Revvity (MEX:PKI) has a PB Ratio of 1.42 as of Jun. 27, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Revvity and its competitors. This is 51% below median its historical median of 2.90. Over the past decade, Revvity's PB Ratio has ranged from 1.28 to 5.06. According to the industry distribution chart, Revvity ranks #82 out of 196 companies in the Medical Diagnostics & Research industry, placing it in the top 41.8%.
Is Revvity's PB Ratio too high?
Revvity's current PB Ratio of 1.42 is 51% below median its 10-year median of 2.90. Over the past 10 years, this metric has ranged from a low of 1.28 to a high of 5.06. The Medical Diagnostics & Research industry median PB Ratio is 2.05. Revvity's value of 1.42 is 30.7% below this industry median. Based on the distribution chart, Revvity ranks #82 out of 196 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Revvity has a GF Score™ of 75/100, reflecting its overall financial health beyond just this single metric.
How does Revvity's PB Ratio compare to MEDP and ICLR?
According to the Medical Diagnostics & Research industry distribution chart, Revvity ranks #82 out of 196 companies for PB Ratio. This puts Revvity in the upper half of its industry. The industry median PB Ratio is 2.05. Revvity's value of 1.42 is 30.7% below this benchmark. Historically, Revvity's own PB Ratio has ranged from 1.28 to 5.06 over the past decade. While the company's 10-year median is 2.90 vs. the industry median of 2.05, Revvity has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Diagnostics & Research company?
The median PB Ratio among Medical Diagnostics & Research companies is 2.05, based on 196 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Revvity's current PB Ratio of 1.42 is 30.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Revvity and its competitors. For the Medical Diagnostics & Research industry, the median PB Ratio is 2.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Revvity's current PB Ratio is 1.42, which is 51% below median its own 10-year median of 2.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Revvity stock overvalued right now?
Revvity (MEX:PKI) has a current PB Ratio of 1.42. The stock's GF Value™ is MXN1,753.57, compared to a current price of MXN1,644.85 — trading 6.2% below its estimated fair value. The current PB Ratio is 1.42, which is 51% below median its 10-year median of 2.90 and 30.7% below the Medical Diagnostics & Research industry median of 2.05. Revvity's overall GF Score™ is 75/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Revvity (MEX:PKI), the current PB Ratio is 1.42 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Revvity (MEX:PKI) Overvalued in 2026?
Based on GuruFocus' analysis, Revvity stock appears to be undervalued.
The current stock price of MXN1,644.85 is trading 6.2% below its estimated GF Value™ of MXN1,753.57.
Key valuation signals for MEX:PKI:
PB Ratio: 1.42 (51% below median its 10-year median of 2.90)
GF Value™: MXN1,753.57 vs. price of MXN1,644.85 (6.2% below fair value)
Industry Position: 30.7% below the Medical Diagnostics & Research median (#82 of 196)
No single metric tells the full story. See the MEX:PKI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
75GF Score
Get the complete analysis for MEX:PKI
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:PKI has been successfully added to your 
